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Past
events
On 2 February 2012, Synektik SA Group officially launched the 
radiopharmaceuticals production in a facility which will serve the 
commercial market. The project finished the two-years’ investment 
by the Company which cost PLN 19 million.
The facility was launched within the Nuclear Medicine Plant of 
Świętokrzyskie Center of Oncology in Kielce. The Centre is among 
the prime centres in Poland serving oncology care, diagnostic 
services, treatment and rehabilitation. The featured dedicated and 
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custom equipped rooms will be used for radio-isotope production, 
synthesis and quality assurance.
The project will help to satisfy large share of the demand for 
radiopharmaceuticals in Poland. It will also make radiopharmaceu-
ticals more accessible for the Polish patients and reduce costs of 
cancer diagnostics in Poland.
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